AGP Executive Report
Last update: 9 hours agoCancer Advances: ESMO 2026 brought promising results for several hard-to-treat cancers: divarasib improved survival in KRAS-mutated lung cancer, while ivonescimab plus chemotherapy extended survival in advanced biliary tract cancer. A long-term prostate cancer analysis also found abiraterone’s survival benefit persisted after nearly eight years. Ebola Response: The DRC outbreak has reached 9,735 reported cases. In Nigeria, health officials are monitoring contacts linked to an imported case and offering isolated people weekly support; Lagos says it has no cases and is strengthening surveillance. Access and Affordability: New Zealand research suggests hospital records miss more than half of people living with multiple chronic conditions, potentially obscuring care needs. In the US, seniors are turning to personal guides to help navigate care, transport and support services. Healthcare Fraud: US authorities announced charges in an alleged $2 billion California healthcare fraud scheme, underscoring concerns about abuse of public programs and insurance. Weight Management: A post-hoc analysis found investigational CagriSema produced substantial weight loss among women across menopause stages, though the findings need confirmation in further research.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
